NEWS
New Feature!!!! University Subject Rankings in 12 branches
FOR SCIENTIST REGISTRATION FOR INSTITUTIONAL BULK REGISTRATION
FOR EDIT YOUR UNIVERSITY / INSTITUTION PAGE
Some differences of the AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
List without CERN, Statistical Data etc. Only in AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
AD
Scientific Index 2024
About Us
Methodology
Compare & Choose
Contact - FAQ
login
Login
person_add
Register
school
University Rankings
subject
University Subject Rankings
place
Country Rankings
insights
i10 Productivity Rankings
insights
Subject Rankings
format_list_numbered
Top 100 Scientists
format_list_numbered
Citation Rankings
format_quote
Top 100 Institutions
local_fire_department
Country Top Lists
Maryalice Stetler-Stevenson
AD Scientific Index 2024
Others
National Cancer Institute - / United States
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Maryalice Stetler-Stevenson's MOST POPULAR ARTICLES
1-)
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trialDW Lee, JN Kochenderfer, M Stetler-Stevenson, YK Cui, C Delbrook, ...The Lancet 385 (9967), 517-528, 201527122015
2-)
Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric …JN Kochenderfer, ME Dudley, SH Kassim, RPT Somerville, RO Carpenter, ...Journal of clinical oncology 33 (6), 540, 201516842015
3-)
B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor–transduced T cellsJN Kochenderfer, ME Dudley, SA Feldman, WH Wilson, DE Spaner, ...Blood, The Journal of the American Society of Hematology 119 (12), 2709-2720, 201216082012
4-)
Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19JN Kochenderfer, WH Wilson, JE Janik, ME Dudley, M Stetler-Stevenson, ...Blood, The Journal of the American Society of Hematology 116 (20), 4099-4102, 201016292010
5-)
CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapyTJ Fry, NN Shah, RJ Orentas, M Stetler-Stevenson, CM Yuan, ...Nature medicine 24 (1), 20-28, 201812702018
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept